Target intelligence / Profile preview

CsbD adhesin (CsbD)

Target
CsbD
Molecular classification
Fimbrial adhesin, Bacterial adhesin, Class 5 (V) fimbriae, Surface protein
01

Overview

CsbD adhesin is the **tip adhesin protein of the CS17 fimbriae**, a class 5 fimbrial structure produced by enterotoxigenic Escherichia coli (ETEC). It mediates the specific binding of bacteria to the host intestinal epithelia, facilitating colonization and infection. Structurally, CsbD consists of two main domains: a lectin (adhesin) domain with a putative receptor-binding site and a pilin domain that anchors the adhesin to the fimbrial shaft, closely resembling the CfaE adhesin of CFA/I fimbriae[1][2]. Mutational analyses indicate that most adaptive changes cluster around the predicted ligand-binding pocket of the lectin domain, emphasizing its role in host interaction and immune evasion[1]. As a critical ETEC colonization factor, CsbD is explored as a potential **vaccine antigen**, with its structural integrity (including β-strands in the pilin domain) contributing to vaccine solubility, stability, and immunogenicity[2]. There are currently no approved drugs targeting CsbD directly, but it is considered a relevant anti-adhesion vaccine candidate.

Other names
CS17 fimbrial adhesinCS17 tip adhesinEnterotoxigenic Escherichia coli CsbD
02

Mechanism of action

Inhibition of adhesion of pathogens to host cells (theoretical for anti-adhesin agents or vaccines); not a direct drug target currently

03

Biological functions

Bacterial adherenceHost cell bindingPathogenesisColonization
04

Disease associations

InfectionDiarrheal diseaseEnteric infection (specifically enterotoxigenic Escherichia coli infection)Other infectious diseases
05

Safety considerations

Antigenic variation may hinder vaccine developmentmutations around the ligand-binding pocket could reduce vaccine efficacy or promote immune escape[1][2]

Beyond the preview

Go deeper on CsbD adhesin (CsbD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CsbD adhesin (CsbD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call